Assessment of common genetic variation in Alzheimer's and Parkinson's diseases reveals global distinction in population attributable risk
Lietsel Jones, Catalina Cerquera‐Cleves, Artur Francisco Schumacher Schuh, Mary B. Makarious, Hirotaka Iwaki, Mike A. Nalls, Alastair John Noyce, Global Parkinson’s Genetics Program (GP2), Cornelis Blauwendraat, Andrew Singleton, Ignacio Fernandez Mata, Mark Cookson, Sara Bandrés‐Ciga
This study assesses genetic variation in Alzheimer's and Parkinson's diseases across ancestries, finding distinct population attributable risks for different loci.
medRxiv · Sep 23, 2024 · PreprintGenetic & Genomic Medicine